Biotech for less than cash value Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than cash value

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: rkrw	12/29/2009 8:18:02 PM
	1 Recommendation of 684

As the year wraps up, here's a list of biotechs that were below cash on hand at 12/31/07, not incl debt. Pretty sorry sight! AGIX: BK OSCI: BK TPPH: BK CRGN: Munched below cash on hand SNUS: RM INHX: still near cash VION: BK PTN: still in the penny's THLD: RS GLGC: name change, RS? NEOL: BK NOVC: RM ANDS: still kicking PANC: BK CJC: barely alive NUVO: RM RDYN: RM ALTU: BK TPTX: RM, basically a zero YMI: still kicking, flat stock Of the top 50, from 639% of cash (ex-debt) to 65% of cash, the performance was atrocious. Even with the big year this year, the only big winners out of 50 were IOMI (munch), ENCY (munch), Cris (3x). * RM Reverse Merge * RS Reverse Split * BK Bankrupt

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next